Vol. 41 No. 2 (2024)

Click for printable Cover

Published: 28-06-2024

  • Race and class in big data

    Logan Harper, Daniel A Culver, Yvette C Cozier
    e2024001
    DOI: https://doi.org/10.36141/svdld.v41i2.16149

  • Association of Area Deprivation Index with Adherence to Proposed Regimen in Patients with Sarcoidosis in Detroit, Michigan

    Medha R Cherabuddi, Benjamin Goodman, Asem Ayyad, Dina A Almajali, Owais Nadeem, Patrick Bradley, Cori Russell, Daniel Ouellette
    e2024031
    DOI: https://doi.org/10.36141/svdld.v41i2.15587

  • Predictive factors of mortality in patients with idiopathic pulmonary fibrosis treated with antifibrotics: a novel prognostic scoring system

    Gülru Polat, Özer Özdemir, Sinem Ermin, Damla Serçe Unat, Fatma Demirci Üçsular
    e2024021
    DOI: https://doi.org/10.36141/svdld.v41i2.13779

  • Prognostic value of coexisting conditions and complications in pleuroparenchymal fibroelastosis: a single-center retrospective study

    Kazuhiko Iwasaki, Satoshi Watanabe, Kazumasa Kase, Noriyuki Ohkura, Keigo Saeki, Yuichi Tambo, Johsuke Hara, Miki Abo, Hideharu Kimura, Seiji Yano
    e2024014
    DOI: https://doi.org/10.36141/svdld.v41i2.13845

  • Immunoglobulin G4-related thoracic disease: clinical and radiological findings of a Turkish cohort

    Aslı Alkan, Gamze Durhan, Gozde Kubra Yardimci, Umran Ozden Sertcelik, Bayram Farisogullari, Macit Ariyurek, Omer Karadag, Deniz Koksal
    e2024030
    DOI: https://doi.org/10.36141/svdld.v41i2.14165

  • The role for endobronchial biopsy in the era of endobronchial ultrasound guided transbronchial needle aspiration for the diagnosis of sarcoidosis: a single center experience Role for EBUS in the diagnosis of sarcoidosis

    Roy Cho, Vidhay Pandey, Jennifer Wong, Joseph Keenan, Erhan Dincer, Emilian Racila, Tadashi Allen, David Perlman, Maneesh Bhargava
    e2024029
    DOI: https://doi.org/10.36141/svdld.v41i2.14192

  • Investigation of respiratory muscle strength and its influence on exercise capacity and quality of life in patients with idiopathic pulmonary fibrosis IPF and Respiratory Muscle Strength

    Esra Pehlivan, Melih Zeren, Elif Yelda Niksarlıoğlu, Fulya Senem Karaahmetoğlu, Zeynep Betül Özcan, Arif Balcı, Barış Demirkol, Erdoğan Çetinkaya
    e2024028
    DOI: https://doi.org/10.36141/svdld.v41i2.14884

  • Osteoporotic bone fracture risk assessment in Latvian patients with newly diagnosed sarcoidosis

    Ieva Ruza, Zane Lucane, Elina Vanaga, Marta Persana, Zane Vitenberga-Verza, Ilze Strumfa
    e2024020
    DOI: https://doi.org/10.36141/svdld.v41i2.15156

  • Prognostic significance of body mass index and weight loss in patients with idiopathic pleuroparenchymal fibroelastosis

    Masato Kono, Takahiko Saito, Tomo Tsunoda, Shin Ikeda, Takahiro Arano, Masayuki Watanuki , Mineo Katsumata, Hideki Miwa, Yoshihiro Miki, Dai Hashimoto, Takafumi Suda, Hidenori Nakamura
    e2024026
    DOI: https://doi.org/10.36141/svdld.v41i2.15291

  • Comparison between diffuse and partial involvement of thoracic lymph nodes on the outcome of sarcoidosis patients

    Ofir Persky, Michael Kassirer, Daniel Ostrovsky, Lydia Osyntsov, Yael Raviv
    e2024016
    DOI: https://doi.org/10.36141/svdld.v41i2.15336

  • The role of biomarkers in the diagnosis and treatment follow-up of idiopathic pulmonary fibrosis

    Abdullah kayıkçı, Fusun Alatas, I.Ozkan Alatas, Huseyın Yıldırım, Hulya Ozen
    e2024015
    DOI: https://doi.org/10.36141/svdld.v41i2.15454

  • Pulmonary function in patients with ANCA-associated vasculitis

    Johannes Dieterich, Bernhard Hellmich, Juliane Mahrhold, You-Shan Feng, Abdallah El Rai, Felix Nessyt, Ulrich Specks, Jürgen Hetzel, Christian Löffler
    e2024025
    DOI: https://doi.org/10.36141/svdld.v41i2.15577

  • .

    Gingival hyperplasia and conjunctival inflammatory nodule: a diagnostic pathway to sarcoidosis?

    Geethu Venugopalan, Rahul Bhandary, Amitha Ramesh
    e2024027
    DOI: https://doi.org/10.36141/svdld.v41i2.15524

  • Bleomycin-induced pulmonary hypertension: an underrated phenomenon with important implications in the setting of high-risk clinical scenarios

    Kenan Yalta, Cafer Zorkun, Ertan Yetkın
    e2024012
    DOI: https://doi.org/10.36141/svdld.v41i2.15479

  • Salvage use of tofacitinib in sarcoidosis patient with refractory multiorgan involvement

    Inês Farinha, Pedro Gonçalo Ferreira
    e2024019
    DOI: https://doi.org/10.36141/svdld.v41i2.15655